Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction
Fabry disease (FD) is an X-linked lysosomal storage disease caused by mutations in GLA, which encodes α-galactosidase A (GLA). The loss or reduced activity of GLA leads to damage to multiple organs, resulting in the intracellular accumulation of globotriaosylceramide in various organs, including the...
Saved in:
Main Authors: | Natsuko Inagaki, Yasuyoshi Takei, Tsuguhisa Hatano, Yasuyuki Takada, Yoshinao Yazaki, Hisanori Kosuge, Masatake Kobayashi, Shinji Suzuki, Tomohiro Umezu, Masahiko Kuroda, Kazuhiro Satomi, Takeharu Hayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426925000114 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
by: Natsuko Inagaki, et al.
Published: (2024-03-01) -
Differential diagnosis of hypertrophic pachymeningitis: literature review
by: G. Makarevičius, et al.
Published: (2022-03-01) -
Fabry cardiomyopathy: Gb3‐induced auto‐reactive panmyocarditis requiring heart transplantation
by: Andrea Frustaci, et al.
Published: (2020-06-01) -
Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
by: LIN Shuantong, et al.
Published: (2025-01-01) -
A case report of idiopathic hypertrophic pachymeningitis
by: G. Makarevičius, et al.
Published: (2022-03-01)